AWS Health Innovation Podcast podcast

#89, Accelerating Drug R&D, Part One of the Health Innovation Compilation Series

0:00
55:13
15 Sekunden vorwärts
15 Sekunden vorwärts
Dive into the groundbreaking approaches of companies like VivoDyne, Seer, Ordaos, Insilico Medicine, and Alchemab, who are pushing boundaries in drug R&D through microfluidic bioengineering, proteome mapping, AI-driven drug design, and resilient antibody discovery.

Weitere Episoden von „AWS Health Innovation Podcast“